These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Comparison of two heparin-coated extracorporeal circuits with reduced systemic anticoagulation in routine coronary artery bypass operations. Ovrum E; Tangen G; Oystese R; Ringdal MA; Istad R J Thorac Cardiovasc Surg; 2001 Feb; 121(2):324-30. PubMed ID: 11174738 [TBL] [Abstract][Full Text] [Related]
8. The impact of heparin-coated cardiopulmonary bypass circuits on pulmonary function and the release of inflammatory mediators. de Vroege R; van Oeveren W; van Klarenbosch J; Stooker W; Huybregts MAJM; Hack CE; van Barneveld L; Eijsman L; Wildevuur CRH Anesth Analg; 2004 Jun; 98(6):1586-1594. PubMed ID: 15155310 [TBL] [Abstract][Full Text] [Related]
9. Biocompatibility of heparin-coated cardiopulmonary bypass circuits in coronary patients with left ventricular dysfunction is superior to PMEA-coated circuits. Kutay V; Noyan T; Ozcan S; Melek Y; Ekim H; Yakut C J Card Surg; 2006; 21(6):572-7. PubMed ID: 17073955 [TBL] [Abstract][Full Text] [Related]
10. The impact of heparin-coated circuits on hemodynamics during and after cardiopulmonary bypass. de Vroege R; Huybregts R; van Oeveren W; van Klarenbosch J; Linley G; Mutlu J; Jansen E; Hack E; Eijsman L; Wildevuur C Artif Organs; 2005 Jun; 29(6):490-7. PubMed ID: 15926987 [TBL] [Abstract][Full Text] [Related]
11. Complement and granulocyte activation in two different types of heparinized extracorporeal circuits. Ovrum E; Mollnes TE; Fosse E; Holen EA; Tangen G; Abdelnoor M; Ringdal MA; Oystese R; Venge P J Thorac Cardiovasc Surg; 1995 Dec; 110(6):1623-32. PubMed ID: 8523872 [TBL] [Abstract][Full Text] [Related]
12. Inflammatory response after coronary revascularization: off-pump versus on-pump (heparin-coated circuits and poly2methoxyethylacrylate-coated circuits). Hazama S; Eishi K; Yamachika S; Noguchi M; Ariyoshi T; Takai H; Odate T; Matsukuma S; Onohara D; Yanatori M Ann Thorac Cardiovasc Surg; 2004 Apr; 10(2):90-6. PubMed ID: 15209550 [TBL] [Abstract][Full Text] [Related]
13. Improved blood cellular biocompatibility with heparin coated circuits during cardiopulmonary bypass. Belboul A; Akbar O; Löfgren C; Jungbeck M; Storm C; Roberts A J Cardiovasc Surg (Torino); 2000 Jun; 41(3):357-62. PubMed ID: 10952323 [TBL] [Abstract][Full Text] [Related]
14. Complement consumption during cardiopulmonary bypass: comparison of Duraflo II heparin-coated and uncoated circuits in fully heparinized patients. Hamulu A; Dişcigil B; Ozbaran M; Calkavur T; Kara E; Kokuludağ A; Büket S; Bilkay O Perfusion; 1996 Jul; 11(4):333-7. PubMed ID: 8884862 [TBL] [Abstract][Full Text] [Related]